Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001373604-25-000014·Adverum Biotechnologies, Inc.
Schedule 13G ownership disclosure
ADVERUM BIOTECHNOLOGIES INC
Common Stock, par value $0.0001 per share · CUSIP: 00773U108
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BML Investment Partners, L.P.
Shares: 2,268,604 · Class: 10.9%
- Leonard Braden Michael
Shares: 2,373,404 · Class: 11.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000014
- Form type
- SCHEDULE 13G/A
- Filer
- Adverum Biotechnologies, Inc.
- CIK
- CIK 1501756
- Filed
- Feb 13, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership